Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$68.49 0.13 (0.19%) as of 4:30 Thu 3/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 97.94(B)
Last Volume: 6,533,471 Avg Vol: 8,519,891
52 Week Range: $47.94 - $67.82
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 199,132 469,488 885,133 1,877,631
Total Sell Value $12,080,496 $26,266,302 $48,317,781 $91,052,440
Total People Sold 6 7 10 15
Total Sell Transactions 12 19 36 74
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 1825
  Page 9 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-11-01 4 S $11.69 $107,982 D/D (9,236) 83,955     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-10-28 4 D $11.58 $10,098 D/D (872) 78,481     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-10-28 4 OE $0.00 $0 D/D 2,594 79,353     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2013-08-29 4 S $10.67 $5,607,309 D/D (525,000) 147,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2013-08-29 4 OE $7.41 $3,519,750 D/D 475,000 535,909     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-08-16 4 S $11.02 $101,420 D/D (9,202) 93,191     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       –      –    2013-08-14 4 S $11.28 $430,630 D/D (38,171) 73,519     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-07-29 4 D $10.97 $24,573 D/D (2,240) 98,149     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-07-29 4 OE $0.00 $0 D/D 6,665 100,389     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-07-29 4 D $10.97 $24,156 D/D (2,202) 73,793     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-07-29 4 OE $0.00 $0 D/D 4,165 75,995     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-07-28 4 D $10.96 $12,396 D/D (1,131) 65,190     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-07-28 4 OE $0.00 $0 D/D 3,364 66,321     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-07-28 4 D $10.96 $844 D/D (77) 25,600     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-07-28 4 OE $0.00 $0 D/D 234 25,677     -
   Prange Karen SVP&Pres, Uro & Womens Health   •       •      –    2013-07-02 4 D $9.17 $77,321 D/D (8,432) 17,430     -
   Prange Karen SVP&Pres, Uro & Womens Health   •       •      –    2013-07-02 4 OE $0.00 $0 D/D 25,862 25,862     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-06-16 4 D $9.51 $59,980 D/D (6,307) 197,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-06-16 4 OE $0.00 $0 D/D 14,665 203,754     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-05-31 4 S $9.36 $102,467 D/D (10,941) 62,957     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-05-30 4 S $9.14 $228,939 D/D (25,001) 19,158     -
   Connors Nelda J Director   •       •      –    2013-05-29 4 S $9.17 $221,144 D/D (24,116) 0     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-05-12 4 D $8.45 $19,934 D/D (2,359) 189,089     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-05-12 4 OE $0.00 $0 D/D 7,235 191,448     -
   Byrnes Bruce L Director   •       •      –    2013-05-07 4 A $0.00 $0 D/D 22,756 98,920     -

  1825 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed